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Bronchus-associated lymphoid tissue (BALT) 
is part of the integrated mucosal immune sys-
tem and is characterized by an aggregation of 
lymphoid cells (1). These aggregations are clus-
tered in follicle-like structures (2) and are com-
posed of B cells surrounded by a parafollicular 
region of T cells. Lymphocytes enter the BALT 
from the blood via high endothelial venules 
(HEVs) and leave via lymphatics. The occur-
rence of BALT diff  ers greatly between species, 
being regularly present, e.g., in rabbits (1). In 
humans, it is not found at birth but arises in chil-
dren and adolescents. In adults, BALT is absent 
in healthy individuals, but its development is 
induced under various disease   conditions such 
as diff  use panbronchiolitis and hypersensitivity 
pneumonitis (for review see reference 3). Fur-
thermore, BALT has been found in lungs 
of cigarette smokers and it has been shown 
that  rats exposed to cigarette smoke have 
enlarged BALT as well as larger areas of bron-
chial epithelium covering BALT (for review 
see reference 3). In mice, BALT is only occa-
sionally present (4) but repetitive inhalations 
with heat-killed bacteria induced BALT devel-
opment in this species (reference 5; unpublished 
data), demonstrating that BALT is inducible 
by infection or infl  ammation very much like 
in human.
A primary adaptive immune response is ini-
tiated in secondary lymphoid organs, such as 
LNs, Peyer’s patches (PP), or spleen. In accor-
dance with that, splenectomized lymphotoxin-
α–defi  cient (LTα−/−) mice or alymphoplastic 
mice (aly/aly), which lack spleen, LNs, and 
Peyer’s patches, are unable to generate pri-
mary immune responses to a variety of patho-
gens, antigens, and allografts (6–8). Surprisingly, 
splenectomized LTα−/− mice infected with 
viruses propagating in the respiratory tract are 
able to generate antigen-specifi  c B and T cells, 
although with delayed kinetics (9, 10). As 
LTα−/− mice are known to develop BALT, 
this suggests that lymphocytes can also be 
primed at sites other than the “classical” lym-
phoid organs, in this case presumably in the 
BALT. Thus, it seems conceivable that induced 
BALT facilitates primary immune responses to 
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respiratory  infections. However, mechanisms that control the 
development of BALT are largely unknown.
In this study we show that mice defi  cient for the chemo-
kine receptor CCR7 possess severely reduced numbers of 
regulatory T cells (T reg cells) in the lung-draining bronchial 
LN (brLN) and that these animals are prone to spontaneously 
develop BALT to a considerable degree without being 
exposed to an immunological insult. We demonstrate that this 
predisposition is of hematopoietic and not stromal origin and 
that CCR7-defi  cient mice start to develop BALT at day 5 
after birth. Adoptive transfer of T reg cells from wild type but 
not CCR7−/− donors into CCR7-defi  cient recipients largely 
interferes with the development of BALT. Furthermore, we 
present data that show that the classical role of T reg cells, 
i.e., the suppression of eff  ector T cells, requires their hom-
ing into lymphoid organs, which in turn is dependent on 
functional CCR7. Along this line, treatment of newborn 
C57BL/6 with a neutralizing anti–l-selectin antibody in-
duced BALT within 1 wk.
RESULTS
CCR7-defi  cient mice spontaneously develop BALT
Upon analysis of the lungs of wild-type and CCR7-defi  cient 
mice by histology, we identifi   ed considerable amounts of 
perivascular and peribronchiolar infi  ltrates in CCR7-defi  cient 
mice that were rarely present in wild-type animals (Fig. 1). 
Immunohistology identifi  ed these infi  ltrates as archetypical 
Figure 2.  Immunohistology of lungs of CCR7-defi  cient mice and 
positioning of BALT within the lung. (A–H) Cryosections of 6–8-wk-old 
CCR7-defi  cient mice were stained with antibodies as indicated. Shown are 
sections representative for 11 animals analyzed. (I) Lungs of CCR7-defi  cient 
mice were cut in 8-μm cryosections. Every 10th section was stained with 
hematoxylin and eosin. From all these sections overviews were achieved 
using automated image assemblies. Areas of BALT were measured. Shown 
is the BALT area per section in dependence of the dorsoventral cutting 
depth of one animal representative of six animals analyzed. (J–L) Cryosections 
of 6–10-wk-old gnotobiotic CCR7-defi  cient mice were stained with anti-
bodies as indicated. Shown are sections representative of seven animals 
analyzed. Bars, 50 μm.
Figure 1.  Histological overview of lungs of wild-type and CCR7-
defi  cient mice. Cryosections of adult lungs from 6–8-wk-old C57BL/6 
mice or CCR7-defi  cient mice were stained with hematoxylin and 
eosin. BALT of CCR7-defi  cient mice is characterized by aggregations of 
lymphoid cells clustered in follicle-like structures. Sections shown are 
representative of 36 CCR7-defi  cient and 15 wild-type animals analyzed. 
Bars, 300 μm.JEM VOL. 204, April 16, 2007  725
ARTICLE
BALT: B cell follicles encircled by a T cell–rich zone harboring 
HEVs (Fig. 2 A), which might support entry of naive 
lymphocytes. The B cell zone consists of IgD+IgM+ as well 
as IgD−IgM+ cells (Fig. 2 B) and contains lymphatic endo-
thelium as revealed by anti–Lyve-1 staining (Fig. 2 C). Cells 
expressing the CCR7 ligand CCL21 primarily cluster through-
out the BALT with some preference for perivascular areas, 
whereas only occasionally could CCL21 be detected on endo-
thelial cells (Fig. 2 D). CXCL13 and CXCL12, ligands for 
CXCR5 and CXCR4, respectively, were primarily found in 
the B cell zone (Fig. 2, E and F). DCs (CD205+) were dis-
tributed all across the lymphoid structures (Fig. 2 G), whereas 
IL7-R+ cells were primarily found in the T cell area (Fig. 
2 H). Furthermore, vascular cell adhesion molecule (VCAM) 
and c-kit (CD117) were also found to be expressed in the 
BALT (not depicted).
Subsequently, we examined the distribution of the BALT 
within the lung by investigating consecutive dorsoventral 
sections through the whole organ (Fig. 2 I). The size of all 
BALT structures identifi  ed was measured and monitored with 
regard to its position within the lung. In CCR7-defi  cient 
mice, BALT is positioned concentric around the main bronchi 
and arteries, whereas only little BALT is found in the periph-
ery of the lung (Fig. 2 I).
As it is known that repetitive inhalations with heat-killed 
bacteria induce BALT in mice, we analyzed germ-free CCR7-
deficient mice to exclude accidental formation of BALT 
caused by environmental bacterial challenge (Fig. 2, J–L). Sim-
ilar to the structures observed in specifi  c pathogen–free (SPF) 
mice, we found BALT in germ-free CCR7−/− mice, al-
though less organized in the latter. B and T zones were not 
separated (Fig. 2 J) although the composition of the B cell 
population was similar to SPF mice (Fig. 2 K). In addition, 
IL7R-positive and -negative T cells were present in BALT of 
gnotobiotic CCR7-defi  cient mice (Fig. 2 L). Furthermore, 
we treated CCR7-defi  cient mice from the second trimester 
of pregnancy until 6 wk after delivery with antibiotics and 
analyzed the off  spring for the occurrence of BALT. Here we 
failed to fi  nd any diff  erence in treated mice compared with 
untreated control mice (unpublished data). Together, these 
data demonstrate that BALT formation in CCR7−/− mice is 
Figure 3.  BALT formation in newborn mice. Cryosections of 4- and 
5-d-old (d4 and d5, respectively) lungs of wild-type (+/+) and CCR7-defi  cient 
(−/−) mice were stained with antibodies as indicated. Bars, 100 μm.
Figure 4.  Lack of CCR7 on hematopoietic cells causes spontaneous 
induction of BALT. (A and B) Stable bone marrow chimeras were pre-
pared as described in Materials and methods using 6–8-wk-old recipients. 
Chimeras showed a peripheral blood donor chimerism >98% when ana-
lyzed 11–12 wk later. Lungs were subjected to immunohistology using 
mAbs as indicated. Transfer of CCR7-defi  cient bone marrow in irradiated 
congenic wild-type recipients resulted in the induction of BALT (B), which 
was not observed after the transfer of wild-type bone marrow (A). Figures 
shown are representative of three animals analyzed per group. Bars: A, 
50 μm; B, 100 μm. (C) Lung sections of 50 and 100% chimeras were ana-
lyzed for the amount of BALT per central lung section (2,000–3,000-μm 
cutting depth; compare Fig. 2 I). (D) Lung sections of wild-type mice, 
which received lymphoid tissue-inducer cells of CCR7-defi  cient mice, 
were analyzed for the amount of BALT per lung section. Each dot repre-
sents one animal analyzed.726  REGULATORY T CELLS AND BALT | Kocks et al.
caused by endogenous factors and is independent of environ-
mental pathogens, although subtle infl  uences on microarchi-
tectural features of the BALT are recognized.
Further analysis revealed that BALT is not present in 
newborn CCR7-defi  cient animals (unpublished data). How-
ever, ICAM- and VCAM-positive clusters containing IL7R+ 
and ckit+ cells were readily detectable in CCR7−/− but not 
in wild-type lungs at day 4 (Fig. 3 and not depicted). From 
day 5 onwards, BALT was present during the entire life span 
of CCR7−/− mice (Fig. 3).
Cells that allow the spontaneous formation of BALT 
in CCR7-defi  cient mice are of hematopoietic origin
To address the cause (hematopoietic vs. nonhematopoietic) 
for the exceptional BALT development in CCR7-defi  cient 
mice, we created bone marrow chimeras. Chimeric mice 
were generated by transplantation of CCR7-defi  cient bone 
marrow into irradiated congenic C57BL/6 Ly5.1 wild-type 
recipients and vice versa. 11 to 12 wk later, chimeras were 
killed and lungs and blood were harvested. Analysis of the 
blood revealed >98% donor chimerism in the periphery (un-
published data). Similar to the phenotype observed in CCR7-
defi  cient animals, lungs of wild-type mice reconstituted with 
CCR7-defi  cient bone marrow showed a marked network of 
BALT (Fig. 4 B). However, the structures in the reconsti-
tuted resembled those identifi  ed in germ-free mice. They 
were less organized than in SPF CCR7-defi  cient animals 
because no T cell ring surrounding the B cell area could be 
identifi  ed (Fig. 4 B and compare Fig. 2 A). As expected, 
transfer of wild-type bone marrow into wild-type animals 
did not result in BALT induction (Fig. 4 A). Interestingly, 
reconstitution of wild-type animals with a mixture of 50% 
CCR7−/− and 50% wild-type bone marrow, which resulted 
in an  50% peripheral chimerism after 11 wk, did not elicit 
BALT formation (Fig. 4 C), whereas reconstitution of wild-
type recipients with 100% CCR7-defi   cient bone marrow 
consistently induced considerable amounts of BALT (Fig. 4 C). 
To examine a possible contribution of lymphoid tissue in-
ducing cells (LTICs) in the formation of BALT, we trans-
ferred LTICs (CD4+CD3−) from CCR7-defi  cient donors 
into newborn wild-type recipients. However, this never re-
sulted in BALT formation (Fig. 4 D). Together, these data 
indicate that a suppressive/regulatory cell population might 
be missing in CCR7−/− mice.
Lack of T reg cells in lung-draining brLNs of CCR7−/− mice
Because T reg cells are known to suppress several   immune 
functions, we tested the hypothesis that a lack in CD4+CD25+ 
T reg cells could be involved in the spontaneous development 
of BALT in CCR7-defi  cient mice. Therefore, we analyzed 
the frequency of T reg cells in diff  erent organs of wild-type 
and CCR7-defi   cient mice. We found that CD4+CD25+ 
T cells are reduced to <10% in all skin-draining peripheral 
LNs but not in the spleen (unpublished data). In lungs of 
CCR7-defi  cient mice, the number of CD4+CD25+ T cells 
was slightly increased (Fig. 5 A). In contrast, in the brLN of 
Figure 5.  Distribution of T reg cells in lung and brLN in wild-type 
and CCR7-defi  cient mice. Leukocytes were isolated from lungs and 
brLN of 6–8-wk-old C57BL/6 and CCR7-defi  cient mice and were stained 
using anti-CD4 and anti-CD25 mAb. (A) Absolute cell counts of T reg cells 
present in the lung and the brLN of wild-type (+/+; open bars) and 
CCR7-defi  cient (−/−; closed bars) mice. (B) CD4+CD25+ cells from brLN 
were analyzed for their expression of CD62L and of CCR7 (CCL19-hIgG). 
(C) brLN CD4+CD25+ cells of wild type and CCR7−/− were further ana-
lyzed for the expression of surface CD62L and intracellular FoxP3. (D) Ratio 
of T reg cells/T naive cells (left), T reg cells/T effector cells (middle), and 
CD62Lhi T reg cells/T effector cells (right) present in the brLN of wild-type 
(open bars) and CCR7-defi  cient (closed bars) mice are shown (wt, n = 5; 
CCR7−/−, n = 4; mean + SD; **, P < 0.01). Similar results were obtained 
in eight wild-type and eight CCR7-defi  cent animals on the BALB/c back-
ground (not depicted).JEM VOL. 204, April 16, 2007  727
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CCR7-defi  cient animals the number of CD4+CD25+ cells 
was again reduced to  10% of that found in wild types (Fig. 
5 A). Because these data suggested that T reg cells require 
CCR7 for LN homing, we analyzed the expression of CCR7 
on CD4+CD25+ brLN cells. In agreement with previous data 
(11), we found that CCR7 is expressed by the vast majority 
of cells within this cell population (Fig. 5 B). Further char-
acterization of the CD4+CD25+ population residing in the 
brLN of wild-type and CCR7-defi  cient mice revealed that 
>95% of them express FoxP3, a transcription factor thought 
to be specifi  c for T reg cells. Interestingly, by analyzing the 
expression of l-selectin on CD4+CD25+FoxP3+ cells, we 
observed that in wild types >50% of these cells coexpressed 
high levels of l-selectin, whereas this cell population was 
nearly completely missing in the brLN of CCR7-defi  cient 
mice (Fig. 5 C).
In addition to the absolute reduction of T reg cell num-
bers in the brLN we also observed a relative reduction of this 
cell population among T cell subsets residing in the brLN of 
CCR7-defi  cient animals. The ratio between regulatory and 
naive T cells in the brLN (number of CD4+CD25+FoxP3+/
number of CD4+CD25−FoxP3−CD62L+) shifted from 0.1 in 
wild-type animals to 0.05 in CCR7−/− mice (Fig. 5 D, left). 
Furthermore, the ratio between all T reg cells and eff  ector 
T cells (CD4+CD25+FoxP3+/CD4+CD25+FoxP3−CD62L; 
Fig. 5 D, middle) decreased from 3.0 in wild type to 0.7 in 
CCR7-defi  cent animals and that of CD62Lhigh T reg cells/
eff  ector T cells from 1.6 to 0.12 (Fig. 5 D, right). Together 
these data demonstrate that CCR7-defi  cient mice carry both 
an absolute and a relative reduction of T reg cells in the brLN 
and that this defi  ciency might be responsible for the sponta-
neous formation of BALT in these mice.
Transfer of wild-type T reg cells into CCR7-defi  cient mice 
reduces BALT in CCR7−/− mice
To investigate the role of CD4+ T reg cells in BALT devel-
opment in CCR7-defi  cient mice, we adoptively transferred 
0.5–1 × 106 T cells of diff  erent phenotype at intervals of 
2 wk into CCR7−/− mice starting at 4–11 d old. Mice were 
killed 2 wk after the last transfer. Consecutive sections of 
whole lungs were stained with hematoxylin and eosin and 
the number of BALT structures were counted. Lungs of 
CCR7-defi  cient recipients receiving CD4+CD25+CD62L+ 
T reg cells from wild-type donors showed a signifi  cant 
decrease in the amount of BALT structures compared with 
lungs of mice treated with CD4+CD25−CD62L+ naive 
T cells derived from wild types or treated with PBS (P < 
0.0001; Fig. 6 A). In contrast, treatments of CCR7- defi  cient 
recipients with T reg cells isolated from CCR7- defi  cient 
donors did not have an eff  ect on BALT reduction (Fig. 6 A). 
This shows that wild-type, but not CCR7-defi  cient, T reg 
cells are able to interfere with BALT existence in CCR7−/− 
mice. To further delineate the eff  ect of T reg cells on BALT 
induction, 1-d-old CCR7-defi  cient mice received either a 
single i.v. injection of PBS or were adoptively transferred 
with 5 × 105 CCR7-profi  cient T reg cells. 6 d after transfer, 
the number of BALT structures was analyzed. In untreated 
mice we found a mean of 6.2 BALT structures per 5 sections 
per lung, whereas this number decreased to 1.1 in animals 
that received T reg cells (Fig. 6 B, left).
Paucity of LN T cell (plt/plt) mice, a naturally occurring 
mutant that lacks expression of the CCR7 ligands CCL19 
and CCL21, as well as CCR7-defi  cient mice show profound 
alterations in thymic T cell development (12). We wondered 
whether the inability of CCR7-defi  cient T reg cells to inter-
fere with BALT development might be caused by develop-
mental defects of T reg cells rather than by impaired homing. 
Because plt/plt and CCR7-defi  cient mice show similar defects 
with regard to thymic T cell development, we hypothesized 
Figure 6.  Transfer of wild-type T reg cells into CCR7-defi  cient 
mice diminishes BALT in CCR7−/− mice. 4–11-d-old CCR7−/− mice 
received PBS or 0.5–1 × 106 sorted cells as indicated three times at 
  intervals of 2 wk. Mice were killed 2 wk after the last transfer. Consecutive 
sections of whole lungs were stained with hematoxylin and eosin and 
the number of BALT structures was counted. Data shown here were 
  obtained and pooled from different experiments (PBS, n = 6; wild-type 
CD4+CD25−CD62L+, n = 6; wild-type CD4+CD25+CD62L+, n = 5; 
CCR7−/− CD4+CD25+CD62L+, n = 2; mean + SD). (B, left) 1-d-old CCR7-
defi  cient mice received 5 × 105 CCR7-profi  cient CD4+CD25+ cells i.v. into 
the superfi  cial temporal vein. Mice were killed 6 d after the transfer (day 7). 
From each recipient, fi  ve sections per lung were analyzed for the presence 
of BALT structures. Shown are results from animals receiving (+; n = 10) 
and animals not receiving (−; n = 13) T reg cells. (B, right) Number of 
BALT structures of CCR7-defi  cient recipients that received T reg cells from 
wild-type (wt) or plt/plt donors (mean + SD; n = 5).728  REGULATORY T CELLS AND BALT | Kocks et al.
that a potential intrinsic defect in T reg cell function would 
also be apparent in T reg cells derived from plt/plt mice. To 
test this hypothesis, we compared the effi   ciency of T reg cells 
of wild-type and plt/plt origin to interfere with BALT devel-
opment in 1-d-old CCR7-defi  cient mice. Interestingly, in 
this experimental setup, wild-type and plt/plt T reg cells were 
equally potent in interfering with BALT development ana-
lyzing the number of BALT structures 6 d after transfer (Fig. 
6 B, right). Because both wild-type and plt/plt-derived T reg 
cells express CCR7, these results suggest that the impaired 
homing rather than a developmental defect of CCR7-defi  cient 
T reg cells seems to be causally involved in BALT develop-
ment in CCR7-defi  cient mice.
Adoptively transferred CCR7-defi  cient T reg cells fail 
to regulate in vivo and are impaired in LN homing
To clarify whether CCR7−/− T reg cells are able to fulfi  ll 
their classical function in vivo, i.e., suppressing eff  ector T cell 
function, we performed adoptive transfer assays using DO11.10 
cells that carry a transgenic T cell receptor specifi  c for OVA. 
To that end, CD4+ CD25− CFSE-labeled DO11.10 cells 
were given i.v. to BALB/c recipients together with equal 
numbers of CD4+CD25+ cells isolated either from DO11.10 
or DO11.10 CCR7−/− donors. Control mice received CD4+ 
CFSE-labeled DO11.10 cells only. On the next day, mice 
were immunized intratracheally with OVA and 3 d later 
mice were killed and the brLN analyzed for the proliferation 
of CFSE-labeled CD4+ cells. Compared with mice that did 
not receive T reg cells, the proliferation of the CFSE-labeled 
reporter cells was signifi  cantly reduced in those recipients 
that also received T reg cells from DO11.10 donors (P < 
0.001; Fig. 7 A). In contrast, adoptive transfer of T reg cells 
of DO11.10 CCR7−/− origin did not aff   ect the T cell 
  proliferation (Fig. 7 A). When we analyzed the brLN for the 
amount of transgenic T reg cells we found substantially fewer 
T reg cells from CCR7-defi  cient DO11.10 donors com-
pared with those from wild-type DO11.10 donors (un-
published data). Although the analyses include cells that 
proliferated after the transfer, these data suggest a defect 
in homing. We therefore adoptively transferred wild-type 
and CCR7-defi   cient lymphocytes from spleen and LNs 
that were depleted for B220+ and CD8+ cells followed by 
labeling with the fl  uorescent dyes TAMRA (carboxytetra-
methylrhodamine) and DDAO (7-hydroxy-9H 1,3-dichloro-9,
9-dimethylacridin-2-one), respectively. After 15 h, recipi-
ents were killed and the   number of naive and T reg cells 
that homed to the bronchial and peripheral LN was deter-
mined. Analyzing CD4+CD25+ T reg cells we found that 
CCR7-deficient cells homed 16 and 30 times less effi-
ciently to the brLN and the inguinal LN,   respectively, com-
pared with wild-type cells (Fig. 7 B). For naive cells 
(CD4+CD25−CD62L+) the diff  erence was less pronounced. 
Here, CCR7−/− cells homed 12 and 17 times less effi   ciently 
to the brLN and the inguinal LN, respectively, compared 
with wild-type cells (Fig. 7 B). These data demonstrate that 
CCR7-defi   cient T reg cells are exquisitely   impaired in 
  homing to the brLN, which as a consequence results in less 
controlled T cell activity.
Figure 7.  Adoptively transferred CCR7-defi  cient T reg cells fail to 
regulate in vivo, are impaired in LN homing, but suppress T cell 
proliferation in vitro. (A) 8–12-wk-old BALB/c recipients received 
equal numbers of CD4+ CD25− CFSE-labeled DO11.10 cells and either 
CD4+CD25+ DO11.10 or CD4+CD25+DO11.10 CCR7−/− cells. As controls, 
other mice received only CD4+ CFSE-labeled DO11.10 cells. 3 d after intra-
tracheal application of OVA, mice were killed and the brLN analyzed for 
proliferation of CFSE-labeled CD4+ cells. The proliferation index was cal-
culated as described in Materials and methods. Shown are data from two 
independent experiments with each symbol representing individual 
animals (***, P ≤ 0.0001). (B) Lymphocytes from spleen and LN of BALB/c and 
CCR7−/− were enriched for CD4+ cells by depleting B220+ and CD8+ 
cells. Cells from wild-type donors were labeled with DDAO and those from 
CCR7-defi  cient donors with TAMRA. Before transfer, cells were adjusted 
to contain equal amounts of CD4+CD25+ cells. 0.5–1 × 106 CD4+CD25+ 
of each genotype were i.v. transferred. 15 h after the transfer, recipients 
were killed and the brLN as well as the inguinal LN were analyzed for the 
presence of naive (CD4+CD25−CD62L+) and regulatory (CD4+CD25+) 
T cells (mean + SD; n = 5 recipients). (C) An in vitro test with DCs, naive 
T cells of OTII Ly5.1 mice, and T reg cells was set up as described in 
Materials and methods. T cells were cultured for 3 d and proliferation of 
OTII Ly5.1 T cells was measured by FACS analysis. Tests were set up in 
duplicates or triplicates. Shown are results from one of three independent 
experiments obtaining similar results.JEM VOL. 204, April 16, 2007  729
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T reg cells of wild-type and CCR7-defi  cient mice 
are equally functional in vitro
To dissect whether CCR7-defi  cient T reg cells are just im-
paired in homing to LN and thereby prevented from exert-
ing regulation or posses an intrinsic defect, we performed in 
vitro assays similar to the in vivo assays described in the pre-
vious paragraph. OVA-loaded wild-type DCs were cultured 
together with CFSE-labeled CD4+CD25− Ly5.1 OTII cells 
in the presence of diff  erent numbers of CD 4+CD25+CD62L+
Ly5.2+ T reg cells isolated either from OTII or OTII-CCR7−/− 
  donors. Analyzing the proliferation of CFSE-labeled cells 
on day 3 failed to reveal any diff  erence in the regulating capa-
bility between the CCR7-defi  cient and wild-type T reg cells 
(Fig. 7 C). This suggests that CCR7-defi  cient T reg cells are 
functionally intact once they have access to the targets they 
regulate on.
Accumulation of FoxP3+ cells in the thymic medulla 
in wild-type and CCR7-defi  cient mice
Several experiments of this study provide evidence that the 
homing of T reg cells to LN depends on CCR7 expression. 
However, because it has been suggested that CCR7 might be 
required for guiding single-positive thymocytes from the cor-
tex into the medulla (13), we compared positioning and num-
ber of thymic T reg cells in wild-type and CCR7-  defi  cient 
mice. Applying immunohistology on frozen thymic sections, 
we observed that in wild-type mice FoxP3+ cells locate to 
a large extent to the thymic medulla and only few FoxP3+ 
cells are present in the cortex (Fig. 8 A). Of interest, a very 
similar picture was obtained for CCR7−/− mice. Again, the 
vast majority of FoxP3+ cells locate to the medulla, whereas 
some disperse through the cortex (Fig. 8 A). Furthermore, 
we failed to observe any signifi  cant diff  erence regarding the 
absolute number of CD4+FoxP3+ cells in the thymus be-
tween both strains (P > 0.05; Fig. 8 B). Together, these data 
argue against an essential role for CCR7 in the corticome-
dullary transit of positively selected FoxP3+ T cells and thus 
support the notion that wild-type and CCR7-defi  cient T reg 
cells might gain comparable intrinsic functionality.
CCR7-defi  cient B cells are not impaired in egressing 
from BALT
It has been recently suggested that lymphocytes might re-
quire CCR7 expression to egress from nonlymphoid organs 
such as skin or lung (14, 15). To address the possibility that 
BALT might develop in CCR7-defi  cient animals because of 
impaired lymphocyte egress, we applied competitive transfer 
of wild-type and CCR7-defi  cient cells to CCR7-defi  cient 
recipients. Because B cells are the major cell population 
contri  buting to BALT in CCR7-defi  cient mice, we injected 
magnetic cell sorting–purifi  ed B cells from wild-type and 
CCR7-defi  cient donors labeled with TAMRA and DDAO, 
respectively, into CCR7-defi  cient recipients. In another series 
of experiments, wild-type and CCR7-defi  cient cells were 
  labeled vice versa. 6 d after transfer recipients were killed and 
the number of wild-type and CCR7-defi  cient B cells present 
in the same BALT structures was determined by histology. 
These experiments revealed that signifi  cantly less adoptively 
transferred CCR7-defi  cient B cells than wild-type B cells 
were present in the BALT (P < 0.01; Fig. 9). These results 
strongly suggest that CCR7-defi  cent B cells are not impaired 
in leaving BALT in CCR7-defi  cient mice.
Induction of BALT in newborn mice 
by anti–L-selectin antibodies
Because 7-d-old CCR7-defi  cient mice already exhibit pro-
nounced BALT, which was substantially reduced after adop-
tive transfer of wild-type T reg cells, we hypothesized that 
it might be possible to induce BALT in wild-type mice by 
interfering with cell homing. Because both l-selectin and 
Figure 8.  CCR7 defi  ciency does not affect localization of FoxP3+ 
cells in the thymus. (A) Cryosections of 8–12-wk-old wild-type B6 
(+/+) and CCR7-defi  cient B6 mice (−/−) were stained with antibodies 
as indicated. Shown are sections representative of four animals analyzed. 
Bars, 200 μm. (B) Thymocytes were isolated from 8–12-wk-old C57BL/6 
and CCR7-deficient mice and stained with antibodies against CD4, 
CD8, and FoxP3. Shown are the number of CD4+CD8−FoxP3+ cells 
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CCR7 are essentially required for lymphocyte homing to 
LN, we treated 3-d-old mice with a single injection of a 
neutralizing anti–l-selectin mAb (Mel-14) or PBS. Analyzing 
the lungs 1 wk later we found BALT structures in all (5/5) 
Mel-14–treated mice with a mean of 3.8 ± 2.5 (mean ± SD) 
BALT structures per 5 sections per lung, whereas not a 
single structure could be found in any of the 5 control mice 
treated with PBS (Fig. 10). Further histological analysis of 
Mel-14–induced BALT revealed the typical BALT architecture 
of CCR7-defi  cient mice at a comparable age: moderately 
organized clusters containing B, T, and VCAM+ (CD106+) 
cells (Fig. 10).
D  I  S  C  U  S  S  I  O  N 
In this study we have investigated the correlation between 
the emergence of BALT and malfunction of T reg cells in 
CCR7-defi  cient mice. We have shown that CCR7-defi  cient 
mice exhibit atypical amounts of BALT. These structures 
harbor all morphological features characteristic for secondary 
lymphoid organs, including the presence of HEV and lym-
phatics. We demonstrate that spontaneous BALT formation 
originates in the hematopoietic system of CCR7-defi  cient 
mice, most likely from the aberrant function of distinct cell 
types derived thereof. Analyzing the distribution of T reg 
cells in diff  erent organs of CCR7−/− mice, we found an 
 90% reduction of this cell population in the brLN in CCR7 
mutants. Furthermore, adoptive transfer of wild-type T reg 
cells into CCR7-defi  cient recipients reverted the occurrence 
of BALT substantially. We also showed that CCR7 defi  -
ciency is linked to a strongly impaired homing of T reg cells 
to LN, where they mediate some of their suppressive func-
tions. In addition, a single injection of a neutralizing anti–l-
selectin mAb in newborn C57BL/6 mice was suffi   cient to 
allow for BALT induction.
Little is known about the development of BALT. In 
mice, BALT does not usually occur regularly, but can be 
  induced by infl  ammatory reactions such as aerosol treatment 
with heat-inactivated Propionibacterium acnes (reference 16; 
unpublished data). Although the development of secondary 
lymphoid organs such as LN and PP and the expression of 
CXCL13 and CCL21 in the spleen are typically dependent 
on LTα (17–19), data provided by Moyron-Quiroz et al. (4) 
show that the formation of BALT and the expression of 
CXCL13 and CCL21 in the lung occurs independently 
of LTα. Consequently, lungs of LTα−/− mice often feature 
BALT (20). The expression of LTα is infl  uenced by infl  am-
matory stimuli and treatment of mice with antibiotics sup-
pressed the spontaneous appearance of BALT in LT-defi  cient 
mice. However, such treatment does not interfere with BALT 
development in CCR7-deficient mice. Furthermore, as 
we fi   nd BALT in lungs of germ-free CCR7-defi  cient 
mutants, the development of BALT in CCR7-defi  cient mice 
seems to occur independently of the presence of infl  amma-
tory stimuli such as pathogen-associated molecular patterns. 
Although BALT is clearly detectable as early as 5 d after birth 
Figure 9.  CCR7 defi  ciency does not cause accumulation of B cells 
in BALT. CCR7-defi  cient BALB/c mice received equal amounts of TAMRA- 
and DDAO-labeled wild-type or CCR7-defi  cient B220+ cells, respectively. 
Cryosections were analyzed for the number of DDAO+ and TAMRA+ cells 
present in BALT structures. In total, 41 BALT structures in four recipients 
were analyzed. Each symbol represents the number of cells identifi  ed in 
individual BALT structures (P < 0.01; paired Student’s t test).
Figure 10.  Treatment of newborn wild types with anti-CD62L mAb 
induces BALT. 3-d-old wild-type mice were i.p. injected with 300 μg 
anti-CD62L mAb (Mel-14). 7 d later, mice were killed. The presence of 
BALT was analyzed as described for Fig. 6 B. Shown are the number of 
BALT structures per fi  ve sections per lung from fi  ve treated and fi  ve un-
treated mice (mean + SD; n = 5; *, P < 0.05, Wilcoxon test). Bars, 50 μm.JEM VOL. 204, April 16, 2007  731
ARTICLE
we cannot formally exclude the possibility that in these 
mice noninfectious stimuli such as dust might contribute to 
BALT formation.
One of the early steps in secondary lymphoid organ devel-
opment is the local accumulation of CD4+CD3− IL-7Rαhi 
LTICs that deliver LT α1β2 signals to resident stromal cells. 
LTICs are capable of inducing the formation of PP as well 
as nasal-associated lymphoid tissue (21, 22). A similar role 
for these cells as inducers of peripheral LNs is also generally 
accepted (23). CCR7-defi  cient mutants occasionally lack the 
inguinal LN, whereas CXCR5−/− mice miss the inguinal, 
brachial, and axillary LNs to varying degrees. Of interest, 
CCR7−/−CXCR5−/− mice lack all peripheral LN but carry 
the mesenteric LN. CD4+CD3− IL-7Rαhi cells express 
CXCR5 as well as CCR7, indicating that both receptors co-
operate during an early step of secondary lymphoid organ 
development. Indeed, it has been demonstrated that the func-
tion of CXCR5 on CD4+CD3− IL-7Rαhi cells can be com-
plemented by CCR7 (24, 25). As LTICs are known to induce 
secondary lymphoid organs, we investigated whether LTICs 
might be involved in triggering the development of BALT 
by their putative aberrant localization to peribronchial areas. 
Although we could never induce BALT by adoptively trans-
ferring CCR7−/− LTICs to wild-type animals, we cannot 
rule out that this might be caused by limitations of our ex-
perimental setup. Thus, it remains to be determined what 
mechanisms are involved in detail in BALT formation. Data 
obtained from CCR7-defi  cient and LTα−/− mice demon-
strate that BALT develops spontaneously in the absence of 
CCR7 signaling. This is of particular interest because it has 
been shown that ectopic expression of CCL21 and to a lesser 
degree that of CCL19 induces ectopic secondary lymphoid 
tissue (26–28). Although it is currently unclear how these, on 
fi  rst sight, contradictory observations contribute to lymphoid 
tissue development it seems likely that they aff  ect diff  erent 
stages of the process. Thus, it seems possible that, in a fi  rst 
step of ectopic lymphoid tissue induction, overexpression 
of CCR7 ligands might be required for the recruitment of 
LITC to locations such as the pancreatic islets, where they 
are not present under physiological conditions. In contrast, 
BALT in CCR7-defi  cient mice regularly develops at posi-
tions where it is also found in wild-type mice, which is con-
sistent with infl  ammatory insults. Therefore, it seems possible 
that the peribronchiolar region represents a “preconditioned” 
area that potentially favors the development of “add on” 
lymphoid tissue once required to fi  ght infection. In such a 
scenario distinct control mechanisms would be required to 
ensure that BALT does not form spontaneously. Here, we 
demonstrate that wild-type T reg cells are able to block 
BALT formation considerably in newborn/young CCR7-
defi   cient animals, suggesting BALT manifestation is con-
trolled by T reg cells. Because adoptively transferred T reg 
cells from plt/plt mice but not from CCR7-defi  cient mice 
effi   ciently suppressed BALT formation, it seems likely that 
unimpaired homing of T reg cells is required for mediating 
the control function. That we could induce BALT in new-
born wild-type mice by injecting a neutralizing anti–l-selectin 
mAb supports this idea.
Another interesting observation obtained in this study re-
lates to the degree of organization of BALT. Although BALT 
is highly organized in CCR7−/− mice kept at SPF condi-
tions, structures present in adult germ-free mice as well as in 
bone marrow chimeras are less organized. These observations 
are reminiscent of those recently reported by Mebius et al. (23). 
In that experimental setup, s.c. injection of newborn LN cells 
induced ectopic lymphoid tissue, which showed little organi-
zation in adult mice, but segregated in T and B areas when 
induced in newborn mice. Interestingly, those disorganized 
aggregates induced in adult mice could be transformed into 
organized tertiary lymphoid tissue after transient immune 
activation (29). Thus it seems plausible that in CCR7−/− 
mice BALT is induced independent of infl  ammatory stimuli, 
whereas some type of immune activation could be required 
to induce segregation of cells.
A role of autoimmune-mediated insults in BALT forma-
tion has been recently suggested by Rangel-Moreno et al. (30). 
In that study it was shown that BALT occurs in patients 
suff  ering from pulmonary complications of autoimmune 
  diseases, such as rheumatoid arthritis and Sjögren syndrome. 
Furthermore, they demonstrate that the presence of BALT 
correlates with lung damage in rheumatoid arthritis patients, 
suggesting a causal link between autoimmunity and BALT 
formation. Along this line, another study revealed that T reg 
cells from patients with rheumatoid arthritis possess reduced 
amounts of FoxP3 at both the messenger RNA and protein 
level and that these T reg cells have reduced suppressive activ-
ity in vitro (31). Because it has been reported that CCR7-
  defi  cient mice are prone to develop autoimmunity (32), it seems 
possible that, in addition to impaired T reg cells homing, self-
reactive cells contribute to BALT formation in these animals.
It has been recently suggested that CCR7 might be in-
volved in the egress of lymphocytes from nonlymphoid organs 
(14, 15). To test the hypothesis that impaired egress of lym-
phocytes from the lung might result in BALT, we competi-
tively transferred B cells from wild-type and CCR7-defi  cient 
donors to CCR7−/− recipients. B cells were chosen because 
they are amply present in BALT. Interestingly, the frequency 
of transferred wild-type B cells present in BALT was consid-
erably higher than that of CCR7−/− origin, rendering the 
hypothesis unlikely that impaired egress essentially contrib-
utes to BALT formation. Along this line, the anti–l-selectin 
mAb used in this study is well known for its ability to prevent 
the recruitment of fast moving cells from the blood stream to 
HEV, whereas there is no evidence available suggesting that 
l-selectin might contribute to lymphocyte egress.
The initial characterization of CCR7-defi  cient mice re-
vealed impaired homing of naive T cells to LN and the splenic 
white pulp, impaired mobilization of DCs from the skin, and, 
as a consequence of both, an impaired functional organization 
of secondary lymphoid organs. Thus, when analyzing the early 
onset of induced immune reactions in these animals we observed 
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whereas the present study points to a role for CCR7 on T reg 
cells in controlling/dampening immune responses. CCR7-
defi  cient mice are also distinguished by a disturbed thymic 
architecture, impaired T cell development, and impaired neg-
ative selection (12, 13, 32), rendering these animals poten-
tially prone to develop autoimmunity. Indeed, it has been 
recently noticed that CCR7−/− and plt/plt mice manifest 
mild autoimmunity to the lachrymal and salivary glands. 
  Although it has not been addressed experimentally in this 
study, it seems possible that impaired negative selection might 
contribute to BALT development and that the transfusion of 
wild-type T reg cells might overcome this defect.
Little is known about the migration pattern of T reg 
cells. Szanya et al. (34) addressed the traffi   cking behavior 
of two subsets of splenic T cells (CD4+CD25+CD62L+ 
and CD4+CD25+CD62L−). They showed that T reg cells 
(CD4+CD25+CD62L+) but not activated T cells (CD4+
CD25+CD62L−) express high levels of CCR7 messenger 
RNA. Because both CD62L and CCR7 are essential for the 
homing of T cells into LNs, these authors hypothesize that 
the characteristic profi  le of adhesion molecule and chemokine 
receptors allows CD4+CD25+CD62L+ T reg cells to effi   -
ciently enter LNs (34). Our data support this hypothesis, as 
we have shown that the expression of CCR7 is necessary for 
the entrance of T reg cells into peripheral LNs. Because of 
the lack of this receptor, T reg cells are strongly impaired in 
entering the lung-draining LN.
T reg cells are known to control immunological processes. 
The majority of naturally arising CD4+ T reg cells express 
CD25, the IL-2 receptor α-chain, and treatment of mice 
with a neutralizing anti–IL-2 mAb selectively reduces the 
number of T reg cells (35). The fi  nding that IL-2–defi  cient 
mice lack CD4+CD25+ T reg cells and develop BALT spon-
taneously (36) links T reg cells to BALT formation. Data pro-
vided in this study put considerable weight to the hypothesis 
that T reg cells are involved in the control of BALT manifes-
tation. We observed that T reg cells are reduced 10-fold in 
the bronchial and other peripheral LN of CCR7-defi  cient 
mice and that transfer of wild-type but not CCR7-defi  cient 
T reg cells into newborn CCR7-defi  cient recipients reduces 
the occurrence of BALT to a considerable degree.
In summary, the present study demonstrates that lack of 
CCR7 provokes the formation of BALT and provides evidence 
that T reg cells are important in controlling BALT formation.
MATERIALS AND METHODS
Mice. CCR7−/− mice have been described previously (33). CCR7-  defi  cient 
mice were backcrossed for at least seven generations to the C57BL/6 or 
BALB/c genetic background. Some histological stainings were also per-
formed on CCR7-defi  cient mice on the original 129SV X BALB/c mixed 
background. C57BL/6Ly5.2, C57BL/6Ly5.1, and BALB/c mice were pur-
chased from Charles River Laboratories. The MHCII-restricted T cell 
receptor transgenic OT-II mice and DO11.10 mice have been described 
previously (37, 38). CCR7-defi  cient mice were bred to DO11.10 mice to 
obtain chemokine receptor–defi  cient, T cell receptor–transgenic mice. All 
animals were maintained under SPF conditions and used at the age of 8–12 
wk or as indicated in the fi  gure legends. Some CCR7-defi  cient mice were 
developed and maintained at germ-free conditions at the animal facility of 
Hannover Medical School as described previously (39). All animal experi-
ments were conducted in accordance with local and institutional guidelines.
Immunohistology. For immunohistology, mice were anesthetized and 
bled to death from the retroorbital plexus. The thorax was opened and the 
lung was perfused with cold PBS via the right heart ventricle. The lung was 
removed, fi  lled via the trachea with OCT Tissue-Tek (Sakura) diluted 1:4 
in PBS, embedded in OCT, and frozen on dry ice. 7–8-μm cryosections 
were prepared, air dried, and fi  xed for 10 min in ice-cold acetone. Cryosec-
tions were blocked with 10% mouse or rat serum and stained with the 
following antibodies: B220-FITC, B220-Cy5 (clone TIB146), CD3-Cy3, 
CD3-Cy5 (17A2), IgM (HB88), IgD (250), CD205 (NLDC-145), and IL7-R 
(A7R34; all grown and labeled in our laboratory); Meca79, MHCII-FITC 
(AF6-120.1), CD11c-biotin (HL3; all from BD Biosciences), goat anti-
CCL21, goat anti-CXCL13 (both from R&D Systems), goat anti-CCL19, 
goat anti-CXCL12 (both from PeproTech), CD11b-FITC (MAC-1), 
B220-biotin, streptavidin-Cy5 (all from Caltag), streptavidin-Cy3, mouse 
anti-goat biotin, mouse anti-rat Cy3 (all from The Jackson Laboratory), 
CD45.2-FITC (104; Chemicon), streptavidin Alexa-488 (Invitrogen), Lyve-1 
(24–228; Acris), CD54-biotin (3E2; BD Biosciences), and CD106 (clone 
429 [MVCAM.A]; BD Biosciences). Cryosections of thymi were blocked 
with 10% rat serum followed by staining with FoxP3-biotin (clone FJK-16s; 
eBioscience) and streptavidin-Cy3. Immunohistological analysis of the lung 
and thymus was done as described previously (12, 40) using a motorized 
microscope (Axiovert M200; Carl Zeiss MicroImaging, Inc.) and KS300 
software (Carl Zeiss MicroImaging, Inc.).
Quantifi  cation of BALT. BALT was analyzed in mice of diff  erent age. In 
adult mice, BALT was prominently developed and always localized around 
or adjacent to the bronchi and vessels (Figs. 1 and 2). The amount of BALT 
present in adult CCR7-defi  cient mice that adoptively received T cells or 
PBS three times (Fig. 6 A) was quantitated as follows: lungs were cut com-
pletely and every 10th section was stained with hematoxylin and eosin. Con-
sequently, on 60–75 sections per mouse the number of BALT structures 
present was determined. Because the size of BALT varied considerably, the 
number of areas consisting of >100 cells was determined. For the analysis of 
lungs of bone marrow chimeras or of mice that received LTICs (Fig. 4) three 
sections were taken at a cutting depth of  1.5, 2.5, and 3.5 mm, respectively 
(compare Fig. 2 I). For the analysis of newborn and young mice (day 0 to 10) 
fi  ve sections per lung were analyzed. After slicing in a dorsoventral direction, 
the criterion for the fi  rst section to be used for analysis was approval of mac-
roscopically visible bronchi. At distances of 400 μm each, four further sec-
tions were subjected to analysis. Each slide analyzed contained all fi  ve plains 
and was stained with anti–B220-Cy3. Lungs were then analyzed for the 
presence of BALT and clusters consisting at least 10 B cells, locating in close 
proximity to each other, were enumerated.
Treatment of pregnant mice with antibiotics. CCR7-defi  cient mice 
were treated from the second trimester of pregnancy onwards until 6 wk   after 
delivery. Mother and off   spring were maintained on 1.25 mg/ml sulfa-
methoxazole and 0.25 mg/ml trimethoprim.
Flow cytometry. For fl  ow cytometry, lungs were cut into small pieces and 
digested for 1 h at 37°C in 0.5 mg/ml PBS/collagenase A (Roche)/ DNaseI 
(20 units/ml; Roche). To obtain single cell suspensions, lungs were minced 
through a nylon mesh, washed with PBS supplemented with 3% FCS fol-
lowed by separation on Lympholyte M (Cedarlane), and counted using a 
Neubaur chamber. Cells were stained using the following antibodies: CD3-
PE (17A2), CD4-PerCp (L3T4), CD11c-FITC (HL3), MHCII (IAd)-biotin 
(IgG3) GR1-PE (RB6-8C5; all from BD Biosciences), CD8-Cy5 (CT-
CD8a), CD25–Alexa-488 (PC61 5.3), CD11b-PE (MAC-1), CD45-APC 
(30F11), CD62L-PE (MEL-14; all from Caltag), CD4 (clone RMCD4), 
B220- Cy5 (clone tip 146), CD19-biotin (6D5; Southern Biotechnology 
Associates, Inc.), and FoxP3-Pe (clone FJK-16s; eBioscience). Thymocytes 
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antibodies: CD25-Alexa 488 (PC61 5.3), CD4 (clone RMCD4), CD8-
APC-Cy7 (clone 53–6.7; BD Biosciences), and FoxP3-PE. Four-color fl  ow 
cytometry was done with a FACS Calibur or an LSRII (BD Biosciences).
Stable bone marrow chimeras. Bone marrow was prepared from femurs 
and tibiae of CCR7-defi  cient (C57BL/6), C57BL/6-Ly5.2, or congenic 
C57BL/6-Ly5.1 mice followed by separation on Lympholyte M. Recipients 
for bone marrow transplantation were 6–8 wk-old sex-matched CCR7-
  defi  cient or congenic C57BL/6-Ly5.1 mice. Before transplantation, adult 
recipient mice were lethally irradiated (5 Gy) twice at an interval of 5 h. 
  Approximately 1.5 × 107 bone marrow cells were transferred to irradiated 
recipients. For 50% chimeras, 50% wild-type and 50% CCR7−/− bone 
  marrow were mixed before transplantation. 11–12 wk later, chimerism was 
determined by FACS of peripheral blood using congenic markers. Chimeric 
mice were killed, and lungs and blood were harvested and analyzed.
Isolation of LTICs. Mesenteric LNs of CCR7-defi  cient C57BL/6 mice 
were isolated and minced through a nylon mesh. Cells were sorted by fl  ow 
cytometry for CD3−CD4+ by negative sorting for B220, CD8, CD11b, 
CD11c, Ter119, GR1, and CD19, and then further for CD3−CD4+. Do-
nors were between embryonic day 19 and 10 d old. Recipients were 0.5–5 
d old. Before transplantation, recipients were irradiated (3.5 Gy) and sorted 
cells were given i.p. or i.v. (1.3 × 103 to 6 × 104 CD3−CD4+ cells). 6 wk 
after transplantation, recipients were killed, and lungs were harvested and 
analyzed for the presence of BALT.
Isolation of CD4+CD25+ and CD4+CD25− T cells. Spleen and periph-
eral LNs of C57BL/6 mice were harvested and minced through a nylon mesh. 
CD4+ cells were isolated with CD4 Macs Microbeads (L3T4) following 
the manufacturer’s instructions (Miltenyi Biotec). CD4+ cells were blocked 
with rat serum and stained using the following antibodies: CD62L-PE, 
CD25–Alexa-488, and CD4-biotin followed by streptavidin-PECy7, B220-
Cy5, and CD8-Cy5. CD4+CD25+CD62Lhigh and CD4+CD25−CD62Lhigh 
T cells were sorted using a FACS Aria (BD Biosciences).
In vitro analysis of T reg cells. Bone marrow–derived DCs were pre-
pared as described previously (40). In brief, bone marrow from femurs 
and tibiae were cultured in RPMI 1640, supplemented with 30 ng/ml 
GM-CSF, 10% FCS, and 50 μM β-mercaptoethanol. At day 1 and 3 of the 
culture, medium was changed and the cells were selected for adherence. 
Additional culture medium was added at day 5. At day 7, cells were har-
vested, washed, and reseeded in culture medium supplemented with 30 ng/ml 
TNF (R&D Systems) and 1μg PGE2 (Sigma-Aldrich) to induce maturation. 
Cells were incubated from day 7 with 1 μg/ml OVA peptide specifi  c for the 
TCR expressed by OT-II cells (OVA323–339 I  S  Q  A  V  H  A  A  H  A  E  I  N  E  A  G  R  ). 
CD4+CD25−OTII Ly5.1 C57BL/6 cells were sorted using a FACS Aria and 
labeled with CFSE as described previously (41). 5 × 104 DCs were cultured 
in 96-well chamber plates with 5 × 104 CD4+CD25−OTII Ly5.1 and T reg 
cells in media containing GMCSF and 50 ng/ml rIL-2. Proliferation of the 
CFSE-labeled CD4+CD25−OTII Ly5.1 cells was measured on day 3 by 
four-color fl  ow cytometry with a FACS Calibur.
Transfer of CD4+CD25+ and CD4+CD25− T cells. 0.5−1 × 106 
CD4+CD25+CD62Lhigh or 1–1.5 × 106 CD4+CD25−CD62Lhigh cells iso-
lated from wild-type or CCR7-defi  cient mice were transferred three times 
at intervals of 2 wk to CCR7−/−B6 mice. Recipients were 4–11 d old at the 
beginning of the transfer and killed 2 wk after the last transfer. The fi  rst in-
jection was given i.p. and the second and the third i.v. In other experiments, 
5 × 105 CD4+CD25+ isolated from wild-type or plt/plt mice were trans-
ferred i.v. into newborn CCR7−/−B6 mice. Recipients were 1 d old at the 
beginning of the transfer and killed 6 d after the transfer (day 7). Results 
were tested for signifi  cance with the unpaired Student’s t test.
In vivo functionality of T reg cells. CD4+ cells of DO11.10 mice and 
CD4+CD25+ cells from DO11.10 or DO11.10 CCR7−/− mice were iso-
lated from spleen and peripheral LNs using the regulatory T cell isolation 
kit following the manufacturer’s instructions (Miltenyi Biotec). CD4+ cells 
of DO11.10 mice were labeled with CFSE as described previously (41). 
1.6 × 106 CD4+ reporter T cells of DO11.10 mice alone or together with 
either CD4+CD25+ of DO11.10 or DO11.10CCR7−/− mice were given 
i.v. 1 d before intratracheal immunization with OVA into BALB/c mice 
(Worthington; 60 μg OVA in 60 μl H20; OVA contained  700 U of LPS/μg). 
3 d after immunization, mice were killed and the brLN was analyzed by 
fl  ow   cytometry for the proliferation of CFSE-labeled CD4+DO11.10 cells and 
the presence of transferred T reg cells. The proliferation index was calculated 
as follows: gates were set around cells of each proliferation cycle. The num-
ber of percent-gated cells in each cycle was divided by 100 and multiplied by 
the number of proliferated cycles. Finally, the calculated values were added up.
Adoptive transfer of T reg cells. Lymphocytes from spleen and LN of 
BALB/c and CCR7−/− were enriched for CD4+ cells by depleting B220+ and 
CD8+ cells (Dynal). Cells from wild-type donors were labeled with DDAO 
(1μM for 10 min at 37°C) and those from CCR7-defi  cient donors with 5(6)-
TAMRA. Before transfer, cells were adjusted to contain equal amounts of 
CD4+CD25+ cells. 0.5–1 × 106 CD4+CD25+ of each genotype were i.v. 
transferred. 15 h after the transfer, recipients were killed and spleen, blood, and 
LNs were harvested. Using mAbs specifi  c for CD4 and CD25, the homing of 
the regulatory as well as naive T cells was assessed by fl  ow cytometry.
Egress of adoptively transferred cells from BALT. B220+ cells of 
Balb/C mice and CCR7−/− Balb/C mice were isolated from spleen using 
MACS MicoBeads following the manufacturer’s instructions (Miltenyi 
  Biotec). B220+ cells were labeled with TAMRA or DDAO as described in 
the previous paragraph and mixed at a ratio of 1:1 before transfer. Wild-type 
cells were labeled with TAMRA, CCR7−/− cells with DDAO, and vice 
versa. 7 × 106 cells of each genotype were transferred i.v. into CCR7−/− 
BALB/c recipients. 6 d after the transfer, mice were killed and the BALT was 
analyzed by histology for the presence of TAMRA+ and DDAO+ cells.
In vivo induction of BALT in C57BL/6 mice by application of a 
neutralizing anti-CD62L mAb. 300 μg anti-CD62L mAb (clone 
Mel-14) was given i.p. into 3-d-old wild-type B6 mice. 7 d later (day 10), 
mice were killed and lungs were harvested and analyzed histologically for the 
presence of BALT.
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